HOOD surges 215% YTD, beating S&P 500! Revenue doubles, EPS up 259%. Trading at 60x forward earnings, analysts see 33% upside.
South Korea will announce a roadmap early next year for inclusion in the MSCI Developed Market Index, targeting long-standing accessibility reforms and potentially unlocking major foreign investment flows into its capital markets.
PBOC is expected to set the USD/CNY reference rate at 7.0112 – Reuters estimate
S&P 500 futures flat after 2-day slump. Traders eye Cheniere Energy & UMB Financial for premarket moves.
IONQ surges 150% from March low, but 400x sales valuation looms. Profitability expected in '26, analysts see 70% upside.
Ultragenyx & Mereo BioPharma stocks crater 90%+ on failed brittle bone drug trials; traders eye risk.
ACHR dips 20% on losses, but eyes 45% upside by 2026 with UAE launch & FAA cert. Risks loom.
Sponsored
Must Read